Global Metabolomics Market Overview:
Metabolomics is the detailed study of small molecules within tissue, cells, or organisms, and their relations within a biological system are known as the metabolome. In other words, Metabolomics is a technology that is highly sophisticated, sensitive, and requires a range of analytical technologies to analyze metabolites in different organisms, tissue, or fluids. Metabolomics is defined as the detailed analysis of metabolites in a biological specimen. It is an emerging technology that holds promise to inform the practice of precision medicine. In past years, small metabolites have been used to diagnose monogenic disorders such as inborn blunders of metabolism and complex metabolic diseases. Currently, metabolomics technologies go well beyond the scope of standard clinical chemistry techniques and can precise analyses of thousands of metabolites. Consequently, metabolomics can provide a detailed characterization of metabolic phenotypes. It can enable precision medicine at several levels, including the description of metabolic derangements that underlie disease, discovering new therapeutic targets, and discovering biomarkers that may be used to either diagnose a disease or monitor the activity of therapeutics.
Global Metabolomics Market Insights
Global Metabolomics market size is projected to grow at a CAGR of over 13.12% during 2020–2027. The growth of the market can be measured to factors such as medical diagnostics in health-care, to product and stress testing in food industries, for instance, identification of potentially harmful bacterial strains and control of pesticides, research in agriculture such as crop protection, substantial equivalence testing, identification of gene function. Metabolomics’ non-invasive nature and its close link to the phenotype make it an ideal tool for the preventive health care pharmaceutical, and agricultural industries. Furthermore, it facilitates scientists and researchers to calculate physiological effects and observe adverse reactions of drugs on an organism. Drug screening and biomarker discovery are prominent examples where metabolomics has already enabled informed decision-making.
Growth Driver
The global metabolomics market growth is increased by the rise in treatment of chronic diseases but at an early stage which could save millions of lives, increase in demand for personalized medicine, and an upsurge in R&D investment for the development of Metabolomics. Over the current years, Metabolomics emerged as a vital tool and shows immense potential in disease diagnostics such as osteoarthritis, diabetes, and cancer. Researchers are increasingly adopting instruments such as chromatography and spectrophotometry. However, the astronomical price of metabolomics instruments hampers the growth of the market. Metabolomics is highly preferable because of improvements in the detection capabilities of current instrumentation techniques used in biomedical research. Since then, the method has been dramatically improved by coupling mass spectrometers to chromatography. There is no single analytical platform that can be used to detect all metabolites in biological samples. Various techniques such as chromatography coupled with mass spectrometry and NMR-spectroscopy are available in metabolomics at present. This is because these techniques can provide excellent resolution to determine individual molecular species. Furthermore, it facilitates scientists and researchers to calculate physiological effects and observe adverse reactions of drugs on an organism and the future applications in personalized medicine resulting in customized treatment strategies.
Product & Service Segmental Analysis
Based on product & service, the global metabolomics market is classified into metabolomics instruments and metabolomics bioinformatics tools & services. The metabolomics instruments segment is further classified into separation techniques and detection techniques. The separation techniques segment is further divided into high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis. The detection techniques segment is further divided into mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis. The metabolomics bioinformatics tools & services segment is further classified into bioinformatics tools & databases and bioinformatics services.
The metabolomics instruments segment accounted for the highest market share in 2019 due to the rising demand for separation techniques in research activities by the bio pharmaceutical & biotechnology industries.
The metabolomics bioinformatics tools & services segment will garner a significant market share in the forecast period. It is attributed to the reliable, rapid, and transparent data processing, high analytical reproducibility, and simplicity of sample preparation.
Application Segmental Analysis
Based on the application, the global metabolomics market is segregated into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others. The biomarker discovery segment held a higher revenue share in 2019 and is projected to dominate the metabolomics market by 2027. It is primarily attributed to the development of therapeutic agents, predicting disease progression, identifying diagnostic & prognostic biomarkers for drug discovery, diagnosis, and management of cardiovascular disease and have an assess the pathophysiological health status of patients, and also enable pharmaceutical companies to analyze and discover novel drugs as demand for cost-effective and efficient treatment dose is increasing.
The toxicology testing segment will garner a significant market share in the forecast period. It is attributed to the advantage of rapid identification of the potential targets of hazardous compounds and allows large-scale screening of drugs.
Indicator Segmental Analysis
Based on Indicators, the global metabolomics market is classified into cancer, cardiovascular disorders, neurological disorders, metabolic disorders, inborn errors of metabolism, and others. The cancer segment will garner higher market potential by 2027. Due to the growing number of cancer patients or the rising prevalence of cancer worldwide, increasing patient assistance programs, increasing government initiatives for cancer awareness, and vital R&D initiatives from key players. The cardiovascular disorders segment will garner a significant market share in the forecast period due to the rising prevalence of heart conditions and the growing geriatric population.
Region Segmental Analysis
The global metabolomics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East. North America is to account for a significant share by 2027 in the metabolomics market. The growth in the region can be attributed to the presence of higher players operating in the metabolic market, increasing biomedical research, rising acceptance of personalized medicine, and the adaption of technologically advanced products.
The Asia Pacific is expected to provide significant growth opportunities due to rising health care needs and increasing metabolic research activities.
Competitor Analysis
Companies such as Agilent Technologies Inc, Thermo Fisher Scientific Inc, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc, Bruker Corporation, Danaher Corporation, Perkinelmer Inc, Dani Instruments S.P.A., Biocrates Life Sciences AG, Leco Corporation, Metabolon Inc, Human Metabolome Technologies, Kore Technologies, Evans Analytical Group LLC, Merck KGaA, Hitachi High-Technologies Corporation, Scion Instruments, SRI Instruments, and JASCO Inc are the key players in the global metabolomics market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global metabolomics technologies manufacturing firm
- Research organizations and consulting companies
- Academic and Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Regulatory bodies
The objective of the research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can significantly affect the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our patients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that can specifically target.
Market Modelling
By Product Type & Services
- Metabolomics Instruments
- Separation Tools
- Gas Chromatography
- High-performance Liquid Chromatography
- Ultra-performance Liquid Chromatography
- Capillary Electrophoresis
- Detection Tools
- Nuclear Magnetic Resonance (NMR) Spectroscopy
- Mass Spectrometry (MS)
- Surface-Based Mass Analysis
- Bioinformatics Tools and Services
- Bioinformatics Services
- Bioinformatics Tools and Databases
By Application
- Biomarker discovery
- Drug discovery
- Toxicology testing
- Nutrigenomics
- Functional Genomics
- Personalized medicine
- Other Applications
By Indication
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Metabolic Disorders
- Inborn Errors of Metabolism
- Other Indications
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- The Middle East
More Related Reports:
Hospital Gowns Market
Baby Food Market
Electrosurgery Market
Medical Gases and Equipment Market
Viral Clearance Market
Eyewear Market
Microarray Analysis Market
Artificial Intelligence in BFSI Market
Low-Code Development Platform Market
Microarray Analysis Market
Global Metabolomics Market
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Supply Chain Analysis
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Technological Landscape
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Global Metabolomics Market Overview
- Market Size & Forecast,2016-2027
- Market Share & Forecast, 2016-2027
- By Product Type & Services
- Metabolomics Instruments
- Bioinformatics Tools and Services
- By Application
- Biomarker discovery
- Drug discovery
- Toxicology testing
- Nutrigenomics
- Functional genomics
- Personalized medicine
- Other applications
- By Indication
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Metabolic Disorders
- Inborn Errors of Metabolism
- Other Indications
- By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- North America Metabolomics Market Overview
- North America Metabolomics Market Size & Forecast, 2016-2027
- North America Metabolomics Market Share & Forecast,2016-2027
- By Product Type & Services
- Metabolomics Instruments
- Bioinformatics Tools and Services
- By Application
- Biomarker discovery
- Drug discovery
- Toxicology testing
- Nutrigenomics
- Functional genomics
- Personalized medicine
- Other applications
- By Indication
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Metabolic Disorders
- Inborn Errors of Metabolism
- Other Indications
- By Country
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on North America Metabolomics Market
- Europe Metabolomics Market Overview
- Europe Metabolomics Market Size & Forecast, 2016-2027
- Europe Metabolomics Market Share & Forecast,2016-2027
- By Product Type & Services
- Metabolomics Instruments
- Bioinformatics Tools and Services
- By Application
- Biomarker discovery
- Drug discovery
- Toxicology testing
- Nutrigenomics
- Functional genomics
- Personalized medicine
- Other applications
- By Indication
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Metabolic Disorders
- Inborn Errors of Metabolism
- Other Indications
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe Metabolomics Market
- Asia Pacific Metabolomics Market Overview
- Asia Pacific Metabolomics Market Size & Forecast, 2016-2027
- Asia Pacific Metabolomics Market Share & Forecast, 2016-2027
- By Product Type & Services
- Metabolomics Instruments
- Bioinformatics Tools and Services
- By Application
- Biomarker discovery
- Drug discovery
- Toxicology testing
- Nutrigenomics
- Functional genomics
- Personalized medicine
- Other applications
- By Indication
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Metabolic Disorders
- Inborn Errors of Metabolism
- Other Indications
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Asia Pacific Metabolomics Market
- South America Metabolomics Market Overview
- South America Metabolomics Market Size & Forecast, 2016-2027
- South America Metabolomics Market Share & Forecast,2016-2027
- By Product Type & Services
- Metabolomics Instruments
- Bioinformatics Tools and Services
- By Application
- Biomarker discovery
- Drug discovery
- Toxicology testing
- Nutrigenomics
- Functional genomics
- Personalized medicine
- Other applications
- By Indication
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Metabolic Disorders
- Inborn Errors of Metabolism
- Other Indications
- By Country
- Brazil
- Argentina
- Rest of South America
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on South America Metabolomics Market
- Middle East & Africa Metabolomics Market Overview
- Middle East & Africa Metabolomics Market Size & Forecast, 2016-2027
- Middle East & Africa Metabolomics Market Share & Forecast, 2016-2027
- By Product Type & Services
- Metabolomics Instruments
- Bioinformatics Tools and Services
- By Application
- Biomarker discovery
- Drug discovery
- Toxicology testing
- Nutrigenomics
- Functional genomics
- Personalized medicine
- Other applications
- By Indication
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Metabolic Disorders
- Inborn Errors of Metabolism
- Other Indications
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Middle East & Africa Metabolomics Market
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- Agilent Technologies Inc
- Thermo Fisher Scientific Inc
- Shimadzu Corporation
- Waters Corporation
- Bio-Rad Laboratories Inc
- Bruker Corporation
- Danaher Corporation
- Perkinelmer Inc
- Dani Instruments SPA.
- Biocrates Life Sciences AG
- Other prominent players